October 8, 2008 - Magnetic resonance imaging (MRI) of the breast continues to show double digit growth in 2008 and is one of the fastest growing procedures in the magnetic resonance departments, reported Arlington Medical Resources (AMR), a provider of premier market intelligence for the pharmaceutical and diagnostic imaging industries.
The newly released edition of the Imaging Market Guide also finds that approximately 90 percent of patients undergoing an MRI of the breast received a contrast agent during the study to improve the delineation between normal and abnormal tissues.
"In the first half of 2008 the total number of patients undergoing MRI of the breast increased 23 percent over the same period in 2007," stated Anna Fisher, analyst at AMR. "This boost may be attributed to increased awareness campaigns for early detection and treatment of breast cancer."
For more information: www.AMR-data.com